Image

A Household-Based Dietary Intervention Study of Vitamin D Fortified Bread in Irish Families

A Household-Based Dietary Intervention Study of Vitamin D Fortified Bread in Irish Families

Recruiting
5-59 years
All
Phase N/A

Powered by AI

Overview

Vitamin D deficiency is common. It is caused by limited sun availability together with a low supply of vitamin D in the food system. There is a high prevalence of low vitamin D status around the world. In Ireland, our relatively northern latitude and prevailing weather mean that UVB availability for skin synthesis of vitamin D is limited in this country and our population relies on the dietary supply of vitamin D to prevent deficiency. Thus, the endemic Irish problem of vitamin D malnutrition is due to the lack of vitamin D in our food system. Dietary guidelines cannot address this issue because foods naturally rich in vitamin D are very few and infrequently consumed.

The FamDBread study will test the hypothesis that a vitamin D-fortified bread as part of a healthy diet that includes vitamin D-fortified foods is effective in preventing low vitamin D status during winter, and safe for families to consume.

Description

This randomised controlled dietary intervention study aims to recruit households/families of children, teens and adults, with 390 participants who will be randomised to receive vitamin D-fortified bread and advice to consume additional commercially available fortified foods (Treatment group) or identical unfortified bread and advice to consume additional commercially available fortified foods (Control group). The outcome of the study is to test whether increasing vitamin D intake through food (Treatment group) is sufficient to prevent wintertime vitamin D deficiency (measured using serum concentrations of 25-hydroxyvitamin D \<30 nmol/L) in comparison with the Control group.

The target vitamin D intake for the treatment group in this study is \>20 μg/ day vitamin D. This will maintain serum concentrations of 25-hydroxyvitamin D (25(OH)D) (the biomarker of vitamin D status) \> 30 nmol/L, the clinical deficiency threshold to prevent metabolic bone disease, in over 90% of participants. At this vitamin D intake level, about 80% of participants will have a 25(OH)D concentration \> 50 nmol/L, the personal intake target in the US and EU.

Eligibility

Inclusion Criteria:

  1. Provide written informed consent if over 16 years; informed parental consent for children under-16 years, plus age-appropriate assent for children under-16 years.
  2. Be a household with at least one adult ≥18 years, with at least one dependent aged 5 years or older.
  3. Willing to consume bread provided and have storage capacity for frozen bread.
  4. Be in good general health.
  5. Be willing to follow the assigned diet for 8 weeks and attend the required appointments.

Exclusion Criteria:

  1. Daily consumption of a vitamin D supplement with a dose exceeding \>10µg/d (400 IU) equivalent.
  2. Exposure to factors that may influence vitamin D status, such as winter sun holiday, ski holiday, tanning beds etc.
  3. Are following a medically prescribed diet.
  4. Have a diagnosis of a medical condition that may interfere with vitamin D absorption, such as Coeliac disease, Inflammatory Bowel Disease, cystic fibrosis, or metabolism, such as liver disease, renal disease.
  5. Have a history of active cancer or a diagnosis of cancer within the past 5 years.
  6. Have an allergy to the bread ingredients.
  7. Are participating in another research study with an intervention or other lifestyle programme that would interfere with the outcomes of the study.
  8. Are unable to read, write, or understand English.

Study details
    Vitamin D Deficiency

NCT07481240

University College Cork

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.